Skip to main content
logo
Barinthus Biotherapeutics plc (FRA:2AB)
Germany flag Germany · Delayed Price · Currency is EUR
0.5850
+0.0200 (3.54%)
Last updated: Jun 10, 2026, 8:02 AM CET

Barinthus Biotherapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--14.970.844.70.27
Revenue Growth (YoY)
--1766.46%-98.21%16580.22%-94.44%
Gross Profit
--14.970.844.70.27
Selling, General & Admin
30.7240.8329.6739.846.3925.12
Research & Development
20.8725.5642.2444.8742.3520.37
Other Operating Expenses
4.444.1611.03---
Operating Income
-56.03-70.56-67.97-83.91-4.04-45.22
Interest Income
1.751.962.682.883.10
Interest Expense
-0.05-0.05-0.05-0.03-0.02-2.67
Other Non-Operating Income (Expense)
1.832.024.124.541.81-3.25
Total Non-Operating Income (Expense)
3.533.926.747.394.89-5.92
Pretax Income
-52.5-66.63-61.23-76.520.85-51.14
Provision for Income Taxes
-0.17-0.18-0.04-3.08-4.47-0.03
Net Income
-52.33-66.46-61.18-73.455.32-51.11
Minority Interest in Earnings
-0.02-0.03-0.11-0.1-0.02-0.25
Net Income to Common
-52.31-66.43-61.07-73.355.34-50.87
Shares Outstanding (Basic)
414139383726
Shares Outstanding (Diluted)
414139383826
Shares Change (YoY)
2.40%3.00%2.50%0.57%47.40%227.59%
EPS (Basic)
-1.29-1.64-1.55-1.910.14-1.96
EPS (Diluted)
-1.29-1.64-1.55-1.910.14-1.96
Shares Outstanding
40.8540.8540.2338.6437.6837.19
Free Cash Flow
-36.48-48.02-29.83-56.34-20.57-33.73
Free Cash Flow Per Share
-0.90-1.18-0.76-1.47-0.54-1.30
Gross Margin
--100.00%100.00%100.00%100.00%
Operating Margin
---454.07%-10463.10%-9.04%-16873.50%
Profit Margin
---408.73%-9157.98%11.90%-19071.60%
FCF Margin
---199.29%-7024.69%-46.01%-12585.40%
EBITDA
-51.36-64.71-62.17-78.490.28-44.62
EBITDA Margin
---415.32%-9786.16%0.63%-16648.90%
EBIT
-56.03-70.56-67.97-83.91-4.04-45.22
EBIT Margin
---454.07%-10463.10%-9.04%-16873.50%
Effective Tax Rate
0.32%0.26%0.07%4.02%-526.00%0.05%